glp 1 chronic kidney disease GLP-1 Receptor Agonists and Diabetic Disease: A Call of Attention to Nephrologists GLP-1 Receptor Agonists in the

10.1073/pnas.97.15.8439 [DOI] [PMC free article] [PubMed] [Google Scholar] 39.Wronkowitz N, Gorgens SW, Romacho T, Villalobos LA, Sanchez-Ferrer CF, Peiro C, et al

They typically subside as your body adjusts to the medication, though they may temporarily return if your provider increases your dosage

[DOI] [PubMed] [Google Scholar] 82.Chi L, Peng L, Pan N, Hu X, Zhang Y

Additionally, treatment with Liraglutide was associated with reduced mean baseline urinary sodium, extracellular volume, natriuresis, N-terminal pro b-type natriuretic peptide (NT-proBNP) and urinary albumin excretion rate, all of which are indicative of its beneficial effects on renal function [87]

Over the following year, his liver enzymes remained mildly elevated but stable, prompting no further evaluation